The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global vision care market reached a value of US$ 63.1 Billion in 2020. Looking forward, IMARC Group expects the market to reach a value of US$ 76.6 Billion by 2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Vision assists in performing everyday activities, such as viewing, writing and reading. It also impacts the ability of an individual to work and communicate with others. However, there has been a significant rise in the number of people suffering from vision-related ailments, such as cataracts, glaucoma, conjunctivitis and retinal detachment. This can be accredited to sedentary lifestyles, growing geriatric population and rising pollution levels. As a result, there is an increase in the development and production of different vision care medicines, which are available in the form of pills, ointments and drops across the globe.
An unhealthy diet and the rising number of chronic conditions have led to a rise in the occurrence of associated vision ailments, which can lead to partial or complete vision loss. Consequently, there is an increase in the demand for vision care products worldwide. Apart from this, numerous international organizations are focusing on research and development (R&D) projects to introduce more efficient products. They are also offering several product variants with improved quality and services to expand their consumer base. Besides this, the flourishing e-commerce sector and the growing awareness about visual impairment caused by UV rays are also propelling the market growth. Some of the key vendors in the industry are also focusing on the prevention of visual impairments with the help of advanced technologies. Moreover, new treatments, such as gene therapy, computerized eye evaluations and stem cell therapy, are anticipated to fuel the market growth in the upcoming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global vision care market report, along with forecasts for growth at the global and regional level from 2021-2026. Our report has categorized the market based on product type and distribution channel.
Breakup by Product Type:
Glass lenses currently exhibit a clear dominance in the market.
Breakup by Distribution Channel:
Retail stores account for the majority of the total market share.
North America enjoys the leading position in the market.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are:
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Distribution Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Companies Covered||Johnson & Johnson Services, Inc., CooperVision, Inc. (Cooper Companies, Inc.), Bausch Health Companies, Inc., Essilor International and Novartis International AG|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at